Cargando...
Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection
Microdose administration of ABY-029, an anti-epidermal growth factor receptor Affibody molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft-tissue sarcomas. The excised tissue of a single patient in the microdose administration group was imaged with both a wi...
Gardado en:
| Publicado en: | Proc SPIE Int Soc Opt Eng |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783124/ https://ncbi.nlm.nih.gov/pubmed/31595101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1117/12.2510935 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|